BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33589694)

  • 1. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
    Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
    Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression.
    Iwamoto C; Ohuchida K; Shinkawa T; Okuda S; Otsubo Y; Okumura T; Sagara A; Koikawa K; Ando Y; Shindo K; Ikenaga N; Nakata K; Moriyama T; Miyasaka Y; Ohtsuka T; Eto M; Akashi K; Nakamura M
    Cancer Lett; 2021 Aug; 512():15-27. PubMed ID: 33961925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
    Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
    Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplasia in Lymph Node Metastasis of Pancreatic Adenocarcinoma Reveals Activation of Cancer-Associated Fibroblasts Pattern and T-helper 2 Immune Cell Infiltration.
    Nizri E; Bar-David S; Aizic A; Sternbach N; Lahat G; Wolf I; Klausner J
    Pancreas; 2019 Mar; 48(3):367-373. PubMed ID: 30768574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
    Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
    Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.
    Cannon AR; Owen MK; Guerrero MS; Kerber ML; Goicoechea SM; Hemstreet KC; Klazynski B; Hollyfield J; Chang EH; Hwang RF; Otey CA; Kim HJ
    Cytoskeleton (Hoboken); 2015 Aug; 72(8):402-11. PubMed ID: 26333695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
    Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
    Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2.
    Malik R; Luong T; Cao X; Han B; Shah N; Franco-Barraza J; Han L; Shenoy VB; Lelkes PI; Cukierman E
    Matrix Biol; 2019 Aug; 81():50-69. PubMed ID: 30412725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
    Pereira BA; Vennin C; Papanicolaou M; Chambers CR; Herrmann D; Morton JP; Cox TR; Timpson P
    Trends Cancer; 2019 Nov; 5(11):724-741. PubMed ID: 31735290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
    Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
    Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
    McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
    Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.